VAERS reports by lot

Pfizer RSV lot HM9849: VAERS reports

23 VAERS reports list lot HM9849 as a Pfizer RSV vaccine, received between 2024-01-05 and 2024-11-05. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
17%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological620%
General / Systemic (non-local)517%
Injection-site / Local reaction517%
Thrombotic / Hematological310%
Musculoskeletal310%
Respiratory27%
Gastrointestinal27%
Cardiac / Cardiovascular13%
Allergic / Anaphylactic13%
Dermatological (non-injection-site)13%
Psychiatric / Neuropsychiatric13%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida3
New York2
Texas2
Wisconsin2
Pennsylvania2
South Carolina2
Massachusetts1
Minnesota1
Illinois1
Washington1
Georgia1
California1

Reports by month received

2024-015
2024-022
2024-032
2024-044
2024-061
2024-085
2024-091
2024-102
2024-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.